Share on StockTwits

Consort Medical plc (LON:CSRT)‘s stock had its “buy” rating reaffirmed by equities researchers at Oriel Securities Ltd in a research report issued on Friday. They currently have a GBX 1,050 ($17.42) price objective on the stock. Oriel Securities Ltd’s price objective points to a potential upside of 10.35% from the stock’s previous close.

Other equities research analysts have also recently issued reports about the stock. Analysts at Numis Securities Ltd upgraded shares of Consort Medical plc to a “buy” rating in a research note on Thursday. They now have a GBX 1,120 ($18.59) price target on the stock, up previously from GBX 940 ($15.60). Separately, analysts at Investec reiterated a “buy” rating on shares of Consort Medical plc in a research note on Thursday. They now have a GBX 1,061 ($17.61) price target on the stock, up previously from GBX 1,021 ($16.94). Finally, analysts at N+1 Singer reiterated a “buy” rating on shares of Consort Medical plc in a research note on Thursday. They now have a GBX 1,100 ($18.25) price target on the stock, up previously from GBX 1,020 ($16.93). One analyst has rated the stock with a sell rating, one has given a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of GBX 1,024.78 ($17.01).

Shares of Consort Medical plc (LON:CSRT) opened at 958.00 on Friday. Consort Medical plc has a one year low of GBX 839.9999 and a one year high of GBX 1113.00. The stock’s 50-day moving average is GBX 918. and its 200-day moving average is GBX 931.. The company’s market cap is £276.4 million.

Consort Medical plc is a healthcare company focused on medical technologies. The principal activities of the Company are the design, development and manufacture of specialty medical drug delivery devices and services to the pharmaceutical industry through its Bespak Division and disposable airway management products for critical care settings in hospitals and pre-hospital settings through its King Systems Division.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.